TAIMEI TECH repurchases 70,000 H shares, representing 0.04% of outstanding stock

Bulletin Express

Jul 20

Zhejiang Taimei Medical Technology Co., Ltd. (TAIMEI TECH) bought back 70,000 H shares on 20 July 2026 via on-exchange transactions, paying an aggregate HKD 0.41 million. The repurchase price ranged from HKD 5.70 to HKD 5.92 per share, with a volume-weighted average of HKD 5.81.

Following the transaction, issued shares (excluding treasury shares) decreased to 197.53 million, while treasury shares increased to 3.06 million. The latest repurchase reduced the company’s outstanding share count by 0.04%.

The buy-back was executed under the mandate approved on 23 June 2026, which authorises the repurchase of up to 20.02 million shares. To date, TAIMEI TECH has repurchased 2.64 million shares under this mandate, equivalent to 1.32% of the issued share capital on the mandate date.

In accordance with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 19 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1198340047"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1198340047\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1198340047?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-20 21:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198340047","market":"us","top_or_hot":-1,"title":"TAIMEI TECH repurchases 70,000 H shares, representing 0.04% of outstanding stock","media":"Bulletin Express","content":"<p>Zhejiang Taimei Medical Technology Co., Ltd. (TAIMEI TECH) bought back 70,000 H shares on 20 July 2026 via on-exchange transactions, paying an aggregate HKD 0.41 million. The repurchase price ranged from HKD 5.70 to HKD 5.92 per share, with a volume-weighted average of HKD 5.81.</p>\n<p>Following the transaction, issued shares (excluding treasury shares) decreased to 197.53 million, while treasury shares increased to 3.06 million. The latest repurchase reduced the company’s outstanding share count by 0.04%.</p>\n<p>The buy-back was executed under the mandate approved on 23 June 2026, which authorises the repurchase of up to 20.02 million shares. To date, TAIMEI TECH has repurchased 2.64 million shares under this mandate, equivalent to 1.32% of the issued share capital on the mandate date.</p>\n<p>In accordance with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 19 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TAIMEI TECH repurchases 70,000 H shares, representing 0.04% of outstanding stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTAIMEI TECH repurchases 70,000 H shares, representing 0.04% of outstanding stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-20 21:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zhejiang Taimei Medical Technology Co., Ltd. (TAIMEI TECH) bought back 70,000 H shares on 20 July 2026 via on-exchange transactions, paying an aggregate HKD 0.41 million. The repurchase price ranged from HKD 5.70 to HKD 5.92 per share, with a volume-weighted average of HKD 5.81.</p>\n<p>Following the transaction, issued shares (excluding treasury shares) decreased to 197.53 million, while treasury shares increased to 3.06 million. The latest repurchase reduced the company’s outstanding share count by 0.04%.</p>\n<p>The buy-back was executed under the mandate approved on 23 June 2026, which authorises the repurchase of up to 20.02 million shares. To date, TAIMEI TECH has repurchased 2.64 million shares under this mandate, equivalent to 1.32% of the issued share capital on the mandate date.</p>\n<p>In accordance with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 19 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02576","symbol_name":"太美医疗科技","start_time":0,"source_url":"","article_id":"1198340047","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198340047","pubTimestamp":1784552506,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zhejiang Taimei Medical Technology Co., Ltd. (TAIMEI TECH) bought back 70,000 H shares on 20 July 2026 via on-exchange transactions, paying an aggregate HKD 0.41 million. The repurchase price ranged...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02576":"太美医疗科技"},"translate_title":"泰美科技回购70,000股H股，占流通股的0.04%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02576":1},"content_text":"Zhejiang Taimei Medical Technology Co., Ltd. (TAIMEI TECH) bought back 70,000 H shares on 20 July 2026 via on-exchange transactions, paying an aggregate HKD 0.41 million. The repurchase price ranged from HKD 5.70 to HKD 5.92 per share, with a volume-weighted average of HKD 5.81.\nFollowing the transaction, issued shares (excluding treasury shares) decreased to 197.53 million, while treasury shares increased to 3.06 million. The latest repurchase reduced the company’s outstanding share count by 0.04%.\nThe buy-back was executed under the mandate approved on 23 June 2026, which authorises the repurchase of up to 20.02 million shares. To date, TAIMEI TECH has repurchased 2.64 million shares under this mandate, equivalent to 1.32% of the issued share capital on the mandate date.\nIn accordance with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 19 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}